Not applicableNo Longer AvailableNCT04355793
What this trial is testing
Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection
Who this might be right for
COVID-19
Incyte Corporation
Showing 20 of 89 results